Bank of Montreal’s AnaptysBio ANAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-50,660
Closed -$1.35M 3482
2021
Q3
$1.35M Buy
+50,660
New +$1.29M ﹤0.01% 2304
2021
Q2
Sell
-1,473
Closed -$32K 3687
2021
Q1
$32K Sell
1,473
-4,022
-73% -$102K ﹤0.01% 3877
2020
Q4
$131K Buy
5,495
+3,561
+184% +$86.5K ﹤0.01% 3440
2020
Q3
$31K Sell
1,934
-640
-25% -$11.5K ﹤0.01% 3621
2020
Q2
$58K Buy
2,574
+2,516
+4,338% +$46K ﹤0.01% 3362
2020
Q1
$1K Sell
58
-3,003
-98% -$45.5K ﹤0.01% 3934
2019
Q4
$50K Buy
3,061
+759
+33% +$17.9K ﹤0.01% 3831
2019
Q3
$80K Buy
2,302
+255
+12% +$12.1K ﹤0.01% 3401
2019
Q2
$115K Buy
+2,047
New +$147K ﹤0.01% 3252
2019
Q1
Sell
-299
Closed -$19K 4292
2018
Q4
$19K Buy
299
+69
+30% +$5.13K ﹤0.01% 3658
2018
Q3
$23K Buy
230
+78
+51% +$6.47K ﹤0.01% 3659
2018
Q2
$10K Buy
+152
New +$12.8K ﹤0.01% 3948
2018
Q1
Sell
-34
Closed -$3K 4151
2017
Q4
$3K Buy
+34
New +$2.5K ﹤0.01% 3990

Other funds holding ANAB

Bank of Montreal's ANAB Position: Q4 2021 in Review

Bank of Montreal sold out of AnaptysBio (ANAB) in Q4 2021, closing a stake of 50,660 shares — an estimated $1.35M sold.

Bank of Montreal first reported a position in ANAB in Q4 2017 and held it in 13 quarters. The position peaked at $1.35M in Q3 2021. 136 funds tracked by Wall St. Rank hold ANAB as of Q4 2021.

  • Bank of Montreal reported no remaining AnaptysBio position as of Q4 2021 after selling out during the quarter.
  • Bank of Montreal sold 50,660 AnaptysBio shares in Q4 2021, an estimated $1.35M.
  • Bank of Montreal first reported a position in AnaptysBio in Q4 2017 and held it in 13 quarters.
  • Bank of Montreal's AnaptysBio position peaked at $1.35M in Q3 2021.
  • 136 funds tracked by Wall St. Rank held AnaptysBio as of Q4 2021.

Based on Bank of Montreal's 13F filing for Q4 2021, filed 11 Feb 2022.